Nanogen Enters Into Supply, License Agreement With deCode

Nanogen, developer of advanced diagnostic products, announced that it has entered into a supply and license agreement with deCode Genetics to provide a new genomics assay for single nucleotide polymorphism (SNP) discovery, validation and screening. The assay incorporates a full range of Nanogen's products, including the Eclipse Dark Quencher, new DNA linker technology, modified bases and novel fluorescent dyes, and allows rapid SNP analysis on a large number of patient samples.

mysan.de (http://www.mysan.de/article80952.html)